Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Reshma Koolaparambil Mukesh"'
Publikováno v:
npj Viruses, Vol 2, Iss 1, Pp 1-10 (2024)
Abstract Coronaviruses (CoVs) have caused three global outbreaks: severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1) in 2003, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012, and SARS-CoV-2 in 2019, with significant mortalit
Externí odkaz:
https://doaj.org/article/01d270e687034fe5bd5bcd3afa81d4a0
Autor:
Reshma Koolaparambil Mukesh, Azeem Abdul Kalam, Joydeep Nag, Vishnu Sunil Jaikumar, Umerali Kunnakkadan, Nisha Asok Kumar, Sreenath Muraleedharan Suma, Arumugam Rajavelu, John Bernet Johnson
Publikováno v:
Molecular Therapy: Oncolytics, Vol 23, Iss , Pp 254-265 (2021)
Chandipura virus (CHPV) is an emerging human pathogen of great clinical significance. In this study, we have investigated the susceptibility pattern of both normal and cancer cell lines of human origin to wild-type (wt) CHPV in order to explore the p
Externí odkaz:
https://doaj.org/article/357f437602cd4b3ebb15dd09b101b6ec
Autor:
Nisha Asok Kumar, Sreenath Muraleedharan Suma, Umerali Kunnakkadan, Joydeep Nag, Reshma Koolaparambil Mukesh, Douglas S. Lyles, John Bernet Johnson
Publikováno v:
Viruses, Vol 13, Iss 3, p 373 (2021)
The human complement system is an important part of the innate immune system. Its effector pathways largely mediate virus neutralization. Vesicular stomatitis virus (VSV) activates the classical pathway of the complement, leading to virus neutralizat
Externí odkaz:
https://doaj.org/article/ccbc9812e81548e9b4d061dbd4072012
Autor:
John B. Johnson, Reshma Koolaparambil Mukesh, Azeem Abdul Kalam, Arumugam Rajavelu, Joydeep Nag, Sreenath Muraleedharan Suma, Vishnu Sunil Jaikumar, Nisha Asok Kumar, Umerali Kunnakkadan
Publikováno v:
Molecular Therapy: Oncolytics, Vol 23, Iss, Pp 254-265 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Chandipura virus (CHPV) is an emerging human pathogen of great clinical significance. In this study, we have investigated the susceptibility pattern of both normal and cancer cell lines of human origin to wild-type (wt) CHPV in order to explore the p
Autor:
Joydeep Nag, Nisha Asok Kumar, Reshma Koolaparambil Mukesh, Umerali Kunnakkadan, John Bernet Johnson
Publikováno v:
Human Microbiome ISBN: 9789811676710
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7707fe421c555f905ec71802db183ac2
https://doi.org/10.1007/978-981-16-7672-7_10
https://doi.org/10.1007/978-981-16-7672-7_10
Autor:
Reshma Koolaparambil Mukesh, Nisha Asok Kumar, Sreenath Muraleedharan Suma, Umerali Kunnakkadan, John B. Johnson, Joydeep Nag
Publikováno v:
J Virol
Chikungunya virus (CHIKV) is an emerging pathogen capable of causing explosive outbreaks. Prior studies showed that exacerbation in arthritogenic alphavirus-induced pathogenesis is attributed to its interaction with multiple immune components, includ
Autor:
Joydeep Nag, Umerali Kunnakkadan, John B. Johnson, Douglas S. Lyles, Reshma Koolaparambil Mukesh, Nisha Asok Kumar, Sreenath Muraleedharan Suma
Publikováno v:
Viruses
Volume 13
Issue 3
Viruses, Vol 13, Iss 373, p 373 (2021)
Volume 13
Issue 3
Viruses, Vol 13, Iss 373, p 373 (2021)
The human complement system is an important part of the innate immune system. Its effector pathways largely mediate virus neutralization. Vesicular stomatitis virus (VSV) activates the classical pathway of the complement, leading to virus neutralizat